Bioimplant with evanescent coating film
US-11278642-B2 · Mar 22, 2022 · US
US11577006B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11577006-B2 |
| Application number | US-202017080460-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 26, 2020 |
| Priority date | Feb 3, 2012 |
| Publication date | Feb 14, 2023 |
| Grant date | Feb 14, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a bioimplant which is capable to inhibit the biofilm formation over a long period of time after an operation. The bioimplant of the present invention comprises a base material of metal, ceramic, or plastic and a thermal spraying film of a calcium phosphate-based material formed at least partially thereon and the silver concentration in the thermal-spray film is 0.05 wt % to 3.00 wt %.
Opening claim text (preview).
What is claimed is: 1. A bioimplant, comprising a base material of the bioimplant; a coating film comprising a calcium phosphate-based material and a silver material formed on at least a part of a surface of the base material; wherein the calcium phosphate-based material comprises oxyapatite and hydroxyapatite, wherein the hydroxyapatite is formed from converting oxyapatite present in the coating into the hydroxyapatite by immersing the coating in deionized water, and wherein fine crystals of the hydroxyapatite are present on a surface of the coating film, wherein a size of the fine crystals of hydroxyapatite is in a range of 0.01 μm to 2.00 μm in length, thickness or width. 2. The bioimplant according to claim 1 , wherein the silver material concentration in the coating film is in a range of 0.05 wt % to 3.00 wt %. 3. The bioimplant according to claim 1 , wherein the base material comprises a metal. 4. The bioimplant according to claim 1 , wherein the calcium phosphate-based material further comprises a compound or a mixture of two or more compounds selected from the group consisting of alpha-tricalcium phosphate, beta-tricalcium phosphate, and tetracalcium phosphate. 5. The bioimplant according to claim 1 , wherein the bioimplant has a bone contact portion, at least part of the bone contact portion is covered with the coating film.
Silver, e.g. silver sulfadiazine · CPC title
Phosphorus-containing materials, e.g. apatite · CPC title
Methods for coating medical devices · CPC title
Biocides, antimicrobial agents, antiseptic agents · CPC title
Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.